Search Weight Loss Topics:

Page 67«..1020..65666768

Category Archives: Testosterone

Older men with ‘low T’ can improve their sex lives with testosterone therapy, study says – Men’s Fitness

Posted: August 17, 2017 at 1:43 pm

We hate to say it, but low testosterone levels can have a slew of negative effects for older guys.

But even now there's a scientific tug-of-war over testosterone-replacement therapy. Sure, it sounds greatwhat guy doesn't want more of the "masculine hormone"?but risks of testosterone therapy can include the growth of pre-existing cancerous cells, testicular shrinkage, infertility, even heart attack or stroke, as one of our writers discovered.

The positives are just as extreme. Aside from increased strength and motivation, men can enjoy greater urinary health, better sexual function, and a higher quality of life, according to new research from Boston University Medical Center.

In the study, published in the Journal of Urology, researchersenrolled roughly 650 men in their 50s and 60s. Some of the men had unexplained testosterone deficiencies, while others suffered from genetic hypogonadism (when gonads fail to produce testosterone). About 360 men received testosterone therapy for eight years (the remaining didn't).

What's more, the men who underwent testosterone therapy enjoyed a significant bump in their urinary and sexual function (lower instance of erectile dysfunction, higher sex drive), as well as better quality of life (sunnier mood, higher confidence).

Another interesting detail: Two men in the treatment group died from causes unrelated to cardiovascular failure, while 21 in the non-treatment group died (19 deaths were cardiovascular-related). Those mortality rates suggested that testosterone therapy isn't necessarily linked to a greater instance of heart attack or stroke, the researchers suggested.

"It is thought that testosterone treatment in men may increase prostate size and worsen lower urinary tract symptoms," study author Abdulmaged Traish, Ph.D., said in a press release. Researchers discovered somemenhad larger prostates post-testosterone therapy, but they experienced fewer instances of frequent urination, incomplete bladder emptying, and waking at night to urinate.

"[Testosterone therapy] is well-tolerated with progressive and sustained improvement in urinary and sexual function, and overall improvement in quality of life," Traish added.

Something to think about if your testosterone takes a hit one day and you want to fight manopause head-on.

Excerpt from:
Older men with 'low T' can improve their sex lives with testosterone therapy, study says - Men's Fitness

Posted in Testosterone | Comments Off on Older men with ‘low T’ can improve their sex lives with testosterone therapy, study says – Men’s Fitness

Testosterone therapy improves urinary, sexual functions: Study – The Hans India

Posted: August 17, 2017 at 1:43 pm

Long-term testosterone replacement therapy improves both sexual and urinary functions as well as quality of life for men suffering from a condition due to deficiency of the hormone, according to a study.

Testosterone is a steroid hormone involved in the regulation of sexual function, urinary health and metabolism as well as a number of other critical functions.For most men, testosterone concentration declines slowly with age and may not cause immediate major symptoms.

However, some men may experience a host of signs and symptoms constituting a clinical condition called Testosterone Deficiency (TD), or male hypogonadism, which is attributed to insufficient levels of testosterone.

As a result, they experience symptoms as varied as erectile dysfunction, low energy, fatigue, depressed mood and an increased risk of diabetes. The study, published in the Journal of Urology, investigated the effects of long-term testosterone replacement therapy on urinary health and sexual function as well as quality of life in men with diagnosed, symptomatic testosterone deficiency.

More than 650 men in their 50s and 60s enrolled in the study, some with unexplained testosterone deficiency and others with known genetic and auto-immune causes for their hypogonadism.

"It is thought that testosterone treatment in men may increase prostate size and worsen lower urinary tract symptoms," said AbdulmagedTraish, Professor of Urology at Boston University School of Medicine in the US.

However, the researchers discovered that despite increased prostate size in the group that received testosterone therapy, there were fewer urinary symptoms such as frequent urination, incomplete bladder emptying, weak urinary stream and waking up at night to urinate.

In addition to these subjective improvements, the researchers conducted objective testing that showed that those men treated with testosterone emptied their bladders more fully.

Finally, testosterone treatment also increased the scores patients received on assessments of their erectile/sexual health and general quality of life, the study said.

See the rest here:
Testosterone therapy improves urinary, sexual functions: Study - The Hans India

Posted in Testosterone | Comments Off on Testosterone therapy improves urinary, sexual functions: Study – The Hans India

Inside an appointment at Seattle Children’s Gender Clinic – KING5.com

Posted: August 15, 2017 at 7:46 am

Elisa Hahn, KING 6:37 PM. PDT August 14, 2017

Dr. David Breland checks Michael Hefferan during a checkup at Seattle Childrens Gender Clinic. (Photo: KING)

Seattle Children's hospital opened one of the first clinics for transgender kids in the state nearly a year ago, and now hundreds of patients from multiple states are seeking its services.

For many kids like Michael Hefferan, the Gender Clinic has opened the door to a new life.

"It was about ninth grade that I came out to everyone at school with my family," Hefferan said.

The 17-year-old remembers hearing about a doctor at Children's who treats trans teenagers and demanded to see him.

"I was pretty much like, 'We need to schedule this as soon as we can. I don't care if it's on my birthday. We need to go in and we need to meet him,'" he said laughing.

Now more than 10 appointments in, Hefferan is here on a Tuesday for a routine checkup.

A nurse takes his vitals, checks his height, weight, and his blood pressure. As part of his transition, the Bothell High School student has been on hormone replacement therapy.

"My voice has gotten a lot deeper," Hefferan said. "I've grown some facial hair. I guess I feel more masculine in my body. I don't know how or why, but I do."

He keeps his medication in a plastic box. A syringe, a notebook where he keeps track of all his injections, his small bottles of testosterone, and band-aids. He administers the shots to himself once every two weeks.

"I just do it right in my stomach, an inch away from the belly button," he said.

Michael Hefferan discusses his physical and emotional health with Dr. David Breland at Seattle Childrens Gender Clinic. (Photo: KING)

This doctor's visit will help determine how the hormone therapy is working.

The appointment is mostly an open dialogue between doctor and patient. Dr. DavidBreland, who heads up the Gender Clinic at Seattle Children's, asks Hefferan how he's feeling, checking in on Hefferan's physical and emotional health.

"Are you dating anyone?" Breland asked.

"No," the teen answered.

The doctor also checks on the impact of the testosterone. Hefferan said he's been noticing facial hair. Breland notes his patient doesn't seem to have any acne.

Hefferan's mom has witnessed dramatic changes in his mood.

"He is so much happier," said Rayna Hefferan. "He's not as mad or as angry at times as he used to be."

Happiness is the goal, according to the clinic's director, and to have the outcome of the particular hormone.

"For testosterone, a lot of my patients want a deeper voice, they want some hair, they want more muscle mass, etc.," said Breland. "And a lot of my patients want to be as 'stealth' as possible. They want to be in the community and perceived as that gender."

"My chest is one of the things that make me most uncomfortable with my body," said Hefferan.

He now binds his chest, a technique used to minimize the appearance of a person's breasts.

"Top surgery is something I've always really wanted from the beginning," said Hefferan. "Just because I bind every day and it's not always the most comfortable."

Seattle Children's does not offer surgeries but provides referrals. For Hefferan, the procedure is on the horizon.

For now,Breland tells him to stay on the same dosage of testosterone, as they wait for his blood test results.

Hefferan is thankful to have a clinic who treats his true self.

"It's really important for the younger kids who come here to have that affirmation that you're okay," he said. "That there is nothing wrong with you for not feeling comfortable with the gender you were assigned when you were born."

Each patient goes through a mental health readiness assessment before starting treatment.

The Gender Clinic now has 250 active patients and hundreds more inquiring about treatment.

2017 KING-TV

See the original post:
Inside an appointment at Seattle Children's Gender Clinic - KING5.com

Posted in Testosterone | Comments Off on Inside an appointment at Seattle Children’s Gender Clinic – KING5.com

Auxilium Pharmaceuticals (NASDAQ:AUXL) & Biogen (BIIB) Financial Review – StockNewsTimes

Posted: August 14, 2017 at 10:44 am

Auxilium Pharmaceuticals (NASDAQ: AUXL) and Biogen (NASDAQ:BIIB) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, valuation, profitability and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Auxilium Pharmaceuticals and Biogen, as provided by MarketBeat.com.

Biogen has a consensus price target of $331.23, indicating a potential upside of 16.76%. Given Biogens higher probable upside, analysts plainly believe Biogen is more favorable than Auxilium Pharmaceuticals.

Institutional & Insider Ownership

88.4% of Biogen shares are owned by institutional investors. 0.3% of Biogen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Auxilium Pharmaceuticals and Biogens net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Auxilium Pharmaceuticals and Biogens top-line revenue, earnings per share (EPS) and valuation.

Biogen has higher revenue and earnings than Auxilium Pharmaceuticals.

Summary

Biogen beats Auxilium Pharmaceuticals on 9 of the 9 factors compared between the two stocks.

Auxilium Pharmaceuticals Company Profile

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company that focuses on developing and marketing products to predominantly specialist audiences. Its core therapeutic focus continues to be in the area of urology, with an anchor position in mens healthcare. The companys products include Testim (testosterone gel) and testosterone gel are indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; TESTOPEL offers men an option that provides a long-acting androgenic effect; Striant (testosterone buccal system) CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; STENDRA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction; among others.

Biogen Company Profile

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkins lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Companys product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Receive News & Ratings for Auxilium Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auxilium Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.

View original post here:
Auxilium Pharmaceuticals (NASDAQ:AUXL) & Biogen (BIIB) Financial Review - StockNewsTimes

Posted in Testosterone | Comments Off on Auxilium Pharmaceuticals (NASDAQ:AUXL) & Biogen (BIIB) Financial Review – StockNewsTimes

Yes, let’s chat about that first female transgender pro cyclist shall we? – Hot Air

Posted: August 10, 2017 at 11:44 am

Weve had a seemingly endless series of discussions about the various aspects of the transgender debate here, many of which focus on the continued and worrisome spread of normalization gender dysphoria in society, the military and beyond. But one of the side-bar aspects of this discussion has had to do with the world of sports. Whether youre talking about a girl wrestling against boys or comparing the Bobby Riggs vs Billy Jean King tennis match to Renee Richards, questions of gender bending in the competitive arena come with all sorts of complications.

Now another sport is being featured in this ongoing debate and its the world of competitive cycling. For the first time a man identifying as a woman will be racing in a USA Cycling sanctioned event in the womens category and competing against some of the top female cyclists. Jillian Bearden (formerly Jonathan) is going to be competing in the Colorado Classic and is able to do so because both the International Olympic Committee and Cycling USA have removed the requirement for transgender athletes to have their transition surgery prior to being able to compete. What theyve done instead is require that men transitioning to be women spend at least one year on medication to suppress their testosterone production, increase estrogen and keep their T levels below a certain, unspecified level. (It will come as no surprise that there are no parallel testing requirements for women identifying as men.) From theDenver Post:

The new rules simply require transwomen to keep testosterone below a certain level for a year before competing and must present a doctors note showing their testosterone levels are below the IOC threshold. The IOC recommendations include no restrictions for athletes transitioning to male.

USA Cycling was one of the first national governing bodies to embrace the new policy, thanks in part to Beardens help. She had the science to support the new rules.

As an elite male racer, she had regular benchmarks measuring her power and lactate threshold. After more than two years of blocking testosterone and boosting estrogen, her wattage output has dropped by 11.4 percent. That mirrors the performance gap between top-tier male and female athletes.

Bearden has done precisely that and claims that his performance has decreased substantially from his days cycling as a man. Because of that, the argument goes, theres no problem with him having any sort of unfair advantage.

Bearden has watched her performance ebb since beginning hormone-replacement therapy in 2015. As testosterone fades and estrogen grows, her fastest times on favorite climbs have slipped into what she calls the gutter.

It was tough realizing her hard-earned power, developed over more than a decade of elite-level bike racing, was waning.

I went from 16 minutes to 26, 27, 28 minutes, she said of her times on her those climbs. I was like holy Testosterone gives you this drive, this oomph, and I didnt have that push.

Ill confess I hadnt given much thought to this aspect of it. The difference in performance levels between men and woman in all of these sports is well known, and letting a guy compete with the women would be grossly unfair. But if you suppress his testosterone levels enough, will his performance really degrade far enough to keep things competitive?

Hed better have suppressed it a lot. I was looking over some of the current records for cycling in the 24 hour competitions on both road and track. (Thats the distance you can ride in 24 hours.) The womens road record currently stands at just under 470 miles. The mens record? 557 miles. The indoor and outdoor track records similarly have a disparity of one hundred miles or more in the mens favor. Is a vastly decreased T level enough to make that much of a difference? While its not being applied to gender dysphoria situations, several medical resources indicate that markedly lower levels have an impact, but precisely how much is unknown and can vary from individual to individual.

Because testosterone plays a role in building muscle, men with low T might notice a decrease in muscle mass. Studies have shown testosterone affects muscle mass, but not necessarily strength or function.

The major problem here is that we dont have a baseline to study. Because of a lack of professional or Olympic records (at least as far as I can find and they arent mentioned in the Denver Post article) we have no idea how great of a cyclist Jonathan Bearden was before he started riding as Jillian Bearden. If he winds up coming in at the back or in the middle of the pack Im sure everyone will be all smiles and say it was great having him in the race. But what has that really proved? The best woman cyclist in the world will no doubt be able to smoke a mediocre male rider while the top flight men would leave her in the dust based on current Olympic records. Were looking at a situation similar in some ways to the aforementioned tennis scenario with Renee Richards. Keep in mind that he was in his mid to late 30s already by the time he was entering tennis full time and was certainly competent, but was only ranked in the top 20 in the over 35 category. Yet when playing as a woman Richards reached a ranking of 20th overall (against the best female players of any age) in 1979 and reached the womens doubles finals at the US Open that year.

That leaves us with an open question as to how well hell do in this race and, perhaps more importantly, how well hell be received. Its been a rousing and supportive welcome thus far, but if Bearden waltzes in there and wins (or comes fairly close) having no real racing bona fides beforehand, do you suppose all of the female competitors are still going to be quite so supportive and welcoming?

Stay tuned. Well have some of those answers later this month.

Originally posted here:
Yes, let's chat about that first female transgender pro cyclist shall we? - Hot Air

Posted in Testosterone | Comments Off on Yes, let’s chat about that first female transgender pro cyclist shall we? – Hot Air

Auxilium Pharmaceuticals Inc – Receive News & Ratings Daily – TheOlympiaReport

Posted: August 10, 2017 at 11:44 am

Auxilium Pharmaceuticals (NASDAQ: AUXL) and Biogen (NASDAQ:BIIB) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitabiliy, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

Insider and Institutional Ownership

88.7% of Biogen shares are held by institutional investors. 0.3% of Biogen shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Auxilium Pharmaceuticals and Biogens revenue, earnings per share and valuation.

Biogen has higher revenue and earnings than Auxilium Pharmaceuticals.

Profitability

This table compares Auxilium Pharmaceuticals and Biogens net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Auxilium Pharmaceuticals and Biogen, as provided by MarketBeat.com.

Biogen has a consensus target price of $331.23, indicating a potential upside of 14.67%. Given Biogens higher possible upside, analysts plainly believe Biogen is more favorable than Auxilium Pharmaceuticals.

Summary

Biogen beats Auxilium Pharmaceuticals on 9 of the 9 factors compared between the two stocks.

About Auxilium Pharmaceuticals

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company that focuses on developing and marketing products to predominantly specialist audiences. Its core therapeutic focus continues to be in the area of urology, with an anchor position in mens healthcare. The companys products include Testim (testosterone gel) and testosterone gel are indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; TESTOPEL offers men an option that provides a long-acting androgenic effect; Striant (testosterone buccal system) CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; STENDRA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction; among others.

About Biogen

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkins lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Companys product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Receive News & Ratings for Auxilium Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auxilium Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.

See the rest here:
Auxilium Pharmaceuticals Inc - Receive News & Ratings Daily - TheOlympiaReport

Posted in Testosterone | Comments Off on Auxilium Pharmaceuticals Inc – Receive News & Ratings Daily – TheOlympiaReport

Testosterone Replacement Therapy – Testosterone Treatment

Posted: August 9, 2017 at 10:47 am

Testosterone is a major sex hormone produced in the testes of men. The pituitary gland is responsible for controlling the production of testosterone hormone. In the testes, luteinizing hormone binds to receptors on Leydig cells; this stimulates production and secretion of testosterone. Testosterone helps to develop the primary and secondary sexual characteristics in males. Development of sex organs, deeper voice, muscle mass, and facial hair all result from the sufficient production of this hormone. Testosterone deficiency as happens with age needs effective testosterone treatment.

Along with the development of sexual features, testosterone hormone also controls the following actions in a body:

With age, testosterone production declines, thus disturbing overall body functioning. Low levels of testosterone hormone lead to a condition termed as hypogonadism that can be treated with testosterone replacement therapy. Hypogonadism can be divided into two categories depending on the occurrence of pathology.

Primary Hypogonadism: It occurs at testicular level with high release of follicle stimulating hormone (FSH), luteinizing hormone (LH), and low release of testosterone.

Secondary Hypogonadism: It occurs at pituitary hypothalamic level with low or in some cases normal release of luteinizing hormone and follicle stimulating hormone along with low levels of testosterone hormone.

Testosterone replacement therapy effectively works to improve upon the conditions of primary and secondary hypogonadism.

Along with aging, there are some other factors that contribute toward low testosterone production and make a man go for testosterone treatment.

Deficient testosterone hormone levels can lead to many undesirable symptoms, like poor libido, lack of vitality, erectile dysfunction, declining muscle mass, osteoporosis, loss of body hair, depression, lower blood hemoglobin, memory loss, poor concentration, mood swings, mild anemia, disturbed cholesterol profile and a decrease in cognitive function that effects all of your activities. Testosterone therapy is the only possible way to cope with testosterone deficiency.

Before start of the testosterone treatment, there should be the right detection of the hormone deficiency. If you consult an expert doctor for testosterone therapy, he may prescribe you the blood test in the morning because testosterone levels are at peak during that time.

We, at Nationwide Synergy Inc, provide patients with best available options to treat their hormone deficiency.

Choosing one best option for testosterone therapy requires consultation with your physician. We have qualified physicians and doctors at our panel who provide expert guidance to the patients.

Stay Young and Healthy with Balanced Hormones Testosterone Replacement Therapy Is Your best Choice!

Originally posted here:
Testosterone Replacement Therapy - Testosterone Treatment

Posted in Testosterone | Comments Off on Testosterone Replacement Therapy – Testosterone Treatment

Trans athlete proves transition is more than a name change – Colorado Daily

Posted: August 9, 2017 at 10:47 am

SALIDA Less than three years into her transition from Jonathan to Jillian, pro cyclist Jillian Bearden has once again found serenity on her bike. Now, using studies and stats collected during her long career, she's helping prove that transgender athletes change more than their names; they change their biology.

Bearden has watched her performance ebb since beginning hormone-replacement therapy in 2015. As testosterone fades and estrogen grows, her fastest times on favorite climbs have slipped into what she calls "the gutter."

It was tough realizing her hard-earned power, developed over more than a decade of elite-level bike racing, was waning.

Jillian Bearden will race in the Colorado Classic, her highest-level event ever after winning the Tour of Tuscon in her big-race debut as a female racer last fall. (Hyoung Chang / The Denver Post)

"I went from 16 minutes to 26, 27, 28 minutes," she said of her times on her those climbs. "I was like holy ... Testosterone gives you this drive, this oomph, and I didn't have that push. My muscles looked fairly big, but I did not have that push to drive that extra energy. I had good days and really, really bad days. But at the end of it all, I always know that I won the biggest race of all. I am here on planet Earth with my family, and it doesn't really matter how slow I am. I've already won."

On Thursday, when Bearden saddles up with the world's best female cyclists for the Colorado Classic in her hometown of Colorado Springs, she will be the first transwoman to race with a pro peloton in the United States. Thanks to recently relaxed International Olympic Committee rules governing transgender athletes, and USA Cycling's embrace of those new rules, Bearden has become a beacon for transathletes across the globe.

Bearden is basking in a light that saved her life. In late 2014, she was driving in the dark and pushed her car to 90 mph. She turned up her favorite tune and prepared to whip the steering wheel and end it all. The darkness was all-consuming, eclipsing all the outward trimmings of success: a family, a home, a job and elite-level talent on a bike.

But just before that fateful yank, Bearden said she felt "an angelic light" penetrate her overwhelming misery. Maybe it was from her mom. Or her brother, who had taken his life almost a decade earlier.

"Whatever it was, that presence brought me out, and the message to me was, 'Tell your mom. Just tell your mom,'" Jillian said.

Jillian told her mom. Then she told her spouse. And her kids. And now she's telling the world that, since her birth, despite the misplaced hardware and the name Jonathan, she is a woman. It's not just that she always wanted to be a woman. She is a woman.

"I would have killed myself that night, and no one would have ever known why. I always knew who I was, but I was in such turmoil," the 36-year-old said, sipping coffee before a high-speed criterium race on rain-soaked streets in Salida.

While she was ready to sacrifice her competitive life in the saddle to claim her gender, she wasn't going to let go of bike racing without a fight. Cycling is her therapy, she said.

"Riding my bike has saved my life many times over," said Bearden, who works as an electrical engineer.

After her brother killed himself in 2005, she pedaled. As she grappled with her gender dysphoria, she pedaled. When suicidal thoughts consumed her, she pedaled. After several thousand hours of training and racing, she was really good. By the time she came so close to ending her life, she had reached the highest levels of amateur cycling on both her mountain and road bikes. Racing was part of her identity. Staying competitive on the bike was vital as she transitioned.

Her growth to Jillian has included more than counseling: hormone therapy to block testosterone and add estrogen, laser hair removal and a public pivot to female. She's also worked with the IOC and USA Cycling to implement new rules for transgender athletes.

The IOC's 2003 rules governing transgender athletes required them to have gender-reassignment surgery to compete in Olympic sports.

"To require surgical anatomical changes as a precondition to participation is not necessary to preserve fair competition and may be inconsistent with developing legislation and notions of human rights," reads the IOC's November 2015 draft guidelines for transgender policies.

The new rules simply require transwomen to keep testosterone below a certain level for a year before competing and must present a doctor's note showing their testosterone levels are below the IOC threshold. The IOC recommendations include no restrictions for athletes transitioning to male.

USA Cycling was one of the first national governing bodies to embrace the new policy, thanks in part to Bearden's help. She had the science to support the new rules.

As an elite male racer, she had regular benchmarks measuring her power and lactate threshold. After more than two years of blocking testosterone and boosting estrogen, her wattage output has dropped by 11.4 percent. That mirrors the performance gap between top-tier male and female athletes.

Bearden says those results have fostered a welcoming environment among her fellow racers. And with her decrease in power documented, she's able to dismiss the argument that she's carrying her years of training and racing as a man into women's racing.

"I'm shocked and I'm blessed and so happy they have embraced me and bought me in and treated me like who I am: a woman," she said. "I think a lot of people have read about my work with the IOC and USAC, and they see my test results from before and after and they see me as legit. I mean, I'm here. I'm a woman. Let's race."

Michelle Henry, a Palmares Racing teammate, has been training with Bearden for several weeks to prepare for the Colorado Classic.

"There are a lot of us who really support her," she said. "As much as her mission is to help others who might be struggling through that really low spot she was in, for many of us, we want to help those people understand there is a lot of acceptance out there and we support them."

Bearden credits the support of her team and family with her mental fight to regain her competitive edge. As her power waned, her push became much more internal.

"The testosterone is gone, so you have to find a new way to get to the new you, and the new me was working on my mental game," she said. "Now it's all mental."

Bearden's steep decline in performance aligns with the first study of transgender athletes, published in 2015 in the Journal of Sporting Cultures and Identities by medical physicist Joanna Harper, who is advising the IOC on its transgender policies. Harper's study showed transwomen runners slowed and lost strength as they blocked testosterone and added estrogen.

Chuck Hodge, the technical director for USA Cycling, consulted with Bearden as American cycling's governing body crafted a policy that welcomed all athletes. With the IOC revising its recommendations for transwomen athletes, USA Cycling didn't need to go through a philosophical or political review, he said, so much as embrace "an update that really modernized our view.

"We basically said this is our policy and this is what's fair and this is what we are doing," he said.

Hodge worked with Bearden through tweaks, like making sure her former name didn't pop up with her times on a race's online results page. "That sounds small, but I can't imagine going through all these changes and then our automated system throws up their old name. Jillian has been very helpful and understanding through the process."

Hodge said he's been "somewhat shocked at the number of calls and emails" from athletes who are following Bearden's lead.

"This wasn't a hard decision," he said. "It's really just treating people fairly and equitably and with respect."

USA Cycling is at the forefront of Olympic-sport governing bodies that are crafting policies for transgender athletes. Athletes like Bearden, with her before-and-after power data, support more science-based decisions, said Ashland Johnson, the director of education and research at the Human Rights Campaign who recently conducted a training for U.S. Olympic Committee coaches and administrators to help embrace athletes of every stripe.

"We are seeing more of a move among governing bodies, where instead of making policies that are dependent on old stereotypes based on gender, decisions are based in science, inclusion and fairness," she said.

Things are moving in the right direction at the international and national level, but more needs to be done at the state level to make sure the Olympic pipeline of younger athletes can include transgender competitors, Johnson said.

"That K-12 arena is where everyone should be able to participate," Johnson said. "We want to increase inclusion at every level of sport, but especially K through 12."

Even with the welcome from her fellow competitors and her rising profile as a transathlete role model, Bearden is quick to admit that not one step of her journey has been easy. But it's better than it ever was.

Last fall, with her wife, Sarah, and their almost 3-year-old daughter cheering her on, she won Arizona's El Tour de Tucson, one of the largest road bike races in the country. The Trans National Women's Cycling Team she co-founded last year has 22 members from 15 states and Mexico. So far this season, she's competed in almost 20 races in Colorado and the West. In late July, she placed fifth in the Salida Classic criterium. The next day, she took third in the event's road race.

The Colorado Classic will be her highest-profile competition.

She's a podium contender, and she's ready for the hate that might bring. She got it aplenty after she won the Tucson race. Her Facebook and Strava pages were quickly stained with anonymous commenters seemingly irked by her talent. Recently, she's had to report online death threats to the police. Transwomen are disproportionately targeted for violence, and transgender people have a high suicide rate, with an estimated 41 percent of transgender adults saying they have attempted to kill themselves.

But for every bucketload of hostility, Bearden says she connects with one person who is inspired by her story. That makes it all worth it, she said. Since she began racing last year, she's developed friendships with more than 50 transgender cyclists across the world eager to follow her lead.

As more step forward to claim their gender, she said, momentum is building.

"I want to use the strength I was given through my transition and send ripples to people everywhere. At the end of the day, it could help save a life for someone in a dark place," she said. "I'm hoping that me being out in the public eye can give people the courage and safety to come out and do what they love and be who they are."

Follow this link:
Trans athlete proves transition is more than a name change - Colorado Daily

Posted in Testosterone | Comments Off on Trans athlete proves transition is more than a name change – Colorado Daily

Jillian Bearden, first female transgender cyclist to ride in a pro US peloton, emerges as beacon for other trans … – The Denver Post

Posted: August 7, 2017 at 1:47 pm

SALIDA Less than three years into her transition from Jonathan to Jillian, pro cyclist Jillian Bearden has once again found serenity on her bike. Now, using studies and stats collected during her long career, shes helping prove that transgender athletes change more than their names, they change their biology.

Bearden has watched her performance ebb since beginning hormone-replacement therapy in 2015. As testosterone fades and estrogen grows, her fastest times on favorite climbs have slipped into what she calls the gutter.

It was tough realizing her hard-earned power, developed over more than a decade of elite-level bike racing, was waning.

I went from 16 minutes to 26, 27, 28 minutes, she said of her times on her those climbs. I was like holy Testosterone gives you this drive, this oomph, and I didnt have that push. My muscles looked fairly big, but I did not have that push to drive that extra energy. I had good days and really, really bad days. But at the end of it all, I always know that I won the biggest race of all. I am here on planet Earth with my family and it doesnt really matter how slow I am. Ive already won.

Hyoung Chang, The Denver Post

On Thursday, when Bearden saddles up with the worlds best female cyclists for the Colorado Classic in her hometown of Colorado Springs, she will be the first transwoman to race with a pro peloton in the United States. Thanks to recently relaxed International Olympic Committee rules governing transgender athletes, and USA Cyclings embrace of those new rules, Bearden has become a beacon for transathletes across the globe.

Bearden is basking in a light that saved her life. In late 2014, she was driving in the dark and pushed hercar to 90 mph. She turned up her favorite tune and prepared to whip the steering wheel and end it all. The darkness was all-consuming, eclipsing all the outward trimmings of success: a family, a home, a job and elite-level talent on a bike.

But just before that fateful yank, Bearden said she felt an angelic light penetrate her overwhelming misery. Maybe it was from her mom. Or her brother, who had taken his life almost a decade earlier.

Whatever it was, that presence brought me out and the message to me was Tell your mom. Just tell your mom, Jillian said.

Jillian told her mom. Then she told her spouse. And her kids. And now shes telling the world, that since her birth, despite the misplaced hardware and the name Jonathan, she is a woman. Its not just that she always wanted to be a woman. She is a woman.

I would have killed myself that night and no one would have ever known why. I always knew who I was, but I was in such turmoil, the 36-year-old said, sipping coffee before a high-speed criterium race on rain-soaked streets in Salida.

While she was ready to sacrifice her competitive life in the saddle to claim her gender, she wasnt going to let go of bike racing without a fight. Cycling is her therapy, she said.

Riding my bike has saved my life many times over, said Bearden, who works as an electrical engineer.

After her brother killed himself in 2005, she pedaled. As she grappled with her gender dysphoria, she pedaled. When suicidal thoughts consumed her, she pedaled. After several thousand hours of training and racing, she was really good. By the time she came so close to ending her life, she had reached the highest levels of amateur cycling on both her mountain and road bikes. Racing was part of her identity. Staying competitive on the bike was vital as she transitioned.

Her growth to Jillian has included more than counseling: hormone therapy to block testosterone and add estrogen, laser hair removal and a public pivot to female. Shes also worked with the IOC and USA Cycling to implement new rules for transgender athletes.

The IOCs 2003 rules governing transgender athletes required them to have gender-reassignment surgery to compete in Olympic sports.

Photo courtesy of Jillian Bearden

To require surgical anatomical changes as a precondition to participation is not necessary to preserve fair competition and may be inconsistent with developing legislation and notions of human rights, reads the IOCs November 2015 draft guidelines for transgender policies.

The new rules simply require transwomen to keep testosterone below a certain level for a year before competing and must present a doctors note showing their testosterone levels are below the IOC threshold. The IOC recommendations include no restrictions for athletes transitioning to male.

USA Cycling was one of the first national governing bodies to embrace the new policy, thanks in part to Beardens help. She had the science to support the new rules.

As an elite male racer, she had regular benchmarks measuring her power and lactate threshold. After more than two years of blocking testosterone and boosting estrogen, her wattage output has dropped by 11.4 percent. That mirrors the performance gap between top-tier male and female athletes.

Bearden says those results have fostered a welcoming environment among her fellow racers. And with her decrease in power documented, shes able to dismiss the argument that shes carrying her years of training and racing as a man into womens racing.

Hyoung Chang, The Denver Post

Im shocked and Im blessed and so happy they have embraced me and bought me in and treated me like who I am: a woman, she said. I think a lot of people have read about my work with the IOC and USAC and they see my test results from before and after and they see me as legit. I mean Im here. Im a woman. Lets race.

Michelle Henry, a Palmares Racing teammate, has been training with Bearden for several weeks to prepare for the Colorado Classic.

There are a lot of us who really support her, she said. As much as her mission is to help others who might be struggling through that really low spot she was in, for many of us, we want to help those people understand there is a lot of acceptance out there and we support them.

Bearden credits the support of her team and family with her mental fight to regain her competitive edge. As her power waned, her push became much more internal.

The testosterone is gone so you have to find a new way to get to the new you and the new me was working on my mental game, she said. Now its all mental.

Beardens steep decline in performance aligns with the first study of transgender athletes, published in 2015 in the Journal of Sporting Cultures and Identities by medical physicist Joanna Harper, who is advising the IOC on its transgender policies. Harpers study showed transwomen runners slowed and lost strength as they blocked testosterone and added estrogen.

Hyoung Chang, The Denver Post

Chuck Hodge, the technical director for USA Cycling, consulted with Bearden as American cyclings governing body crafted a policy that welcomed all athletes. With the IOC revising its recommendations for transwomen athletes, USA Cycling didnt need to go through a philosophical or political review, he said, so much as embrace an update that really modernized our view.

We basically said this is our policy, and this is whats fair, and this is what we are doing, he said.

Hodge worked with Bearden through tweaks, like making sure her former name didnt pop up with her times on a races online results page. That sounds small, but I cant imagine going through all these changes and then our automated system throws up their old name. Jillian has been very helpful and understanding through the process.

Hodge said hes been somewhat shocked at the number of calls and emails from athletes who are following Beardens lead.

This wasnt a hard decision, he said. Its really just treating people fairly and equitably and with respect.

USA Cycling is at the forefront of Olympic-sport governing bodies that are crafting policies for transgender athletes. Athletes like Bearden, with her before-and-after power data, support more science-based decisions, said Ashland Johnson, the director of education and research at the Human Rights Campaign who recently conducted a training for U.S. Olympic Committee coaches and administrators to help embrace athletes of every stripe.

Hyoung Chang, The Denver Post

We are seeing more of a move among governing bodies, where instead of making policies that are dependent on old stereotypes based on gender, decisions are based in science, inclusion and fairness, she said.

Things are moving in the right direction at the international and national level, but more needs to be done at the state level, to make sure the Olympic pipeline of younger athletes can include transgender competitors, Johnson said.

That K-12 arena is where everyone should be able to participate, Johnson said. We want to increase inclusion at every level of sport, but especially K-through-12.

Even with the welcome from her fellow competitors and her rising profile as a transathlete role model, Bearden is quick to admit that not one step of her journey has been easy. But its better than it ever was.

Last fall, with her wife Sarah and their almost 3-year-old daughter cheering her on, she won Arizonas El Tour de Tucson, one of the largest road bike races in the country. The Trans National Womens Cycling Team she co-founded last year has 22 members from 15 states and Mexico. So far this season shes competed in almost 20 races in Colorado and the West. In late July she placed fifth in the Salida Classic criterium. The next day she took third in the events road race.

The Colorado Classic will be her highest profile competition.

Hyoung Chang, The Denver Post

Shes a podium contender and shes ready for the hate that might bring. She got it aplenty after she won the Tucson race. Her Facebook and Strava pages were quickly stained with anonymous commenters seemingly irked by her talent. Recently shes had to report online death threats to the police. Transwomen are disproportionately targeted for violence and transgender people have a high suicide rate, with an estimated 41 percent of transgender adults saying they have attempted to kill themselves.

But for every bucketload of hostility, Bearden says she connects with one person who is inspired by her story. That makes it all worth it, she said. Since she began racing last year, shes developed friendships with more than 50 transgender cyclists across the world eager to follow her lead.

As more step forward to claim their gender, she said, momentum is building.

I want to use the strength I was given through my transition and send ripples to people everywhere. At the end of the day it could help save a life for someone in a dark place, she said. Im hoping that me being out in the public eye can give people the courage and safety to come out and do what they love and be who they are.

More here:
Jillian Bearden, first female transgender cyclist to ride in a pro US peloton, emerges as beacon for other trans ... - The Denver Post

Posted in Testosterone | Comments Off on Jillian Bearden, first female transgender cyclist to ride in a pro US peloton, emerges as beacon for other trans … – The Denver Post

Top urology doctor offers award-winning treatments – Simi Valley Acorn

Posted: August 6, 2017 at 11:44 am

Dr. Bellman For over 20 years, Dr. Gary Bellman, founder of the Southern California Urology Institute, has treated Southern Californians suffering from myriad urological disorders.

The board-certified urologist has received awards including Patients Choice and Compassionate Doctor of the Year.

Bellman is often featured on television, radio and in print where he explains the benefits of treatments including the no-needle, no-scalpel vasectomy; testosterone hormone replacement therapy; minimally invasive kidney stone treatments; and the latest effective solutions to treat prostate problems.

He is a board-certified urologist.

Bellman founded the SoCal Urology Institute to provide the most advanced urological treatments available, including the no-needle, no-scalpel vasectomy, a 20-minute outpatient contraceptive procedure that is nearly pain-free. To date, Bellman has performed thousands of these procedures.

For men suffering from hypog onadism/ low testosterone (Low T), Bellman uses emerging treatments, including testosterone injection therapy.

In treating kidney stones, he uses the most sophisticated treatments available, including shock-wave lithotripsy, ureteroscopy and tubeless percutaneous nephrolithotomy.

Bellman also treats men with enlarged prostate problems and their disruptive symptoms by using minimally invasive surgical treatments such as the UroLift System and green light laser.

See more here:
Top urology doctor offers award-winning treatments - Simi Valley Acorn

Posted in Testosterone | Comments Off on Top urology doctor offers award-winning treatments – Simi Valley Acorn

Page 67«..1020..65666768